S Kaye

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.

K. Gelmon, S. Domchek, U. Matulonis, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

I Judson, I. Judson, U. Banerji, 2009, British Journal of Cancer.

Targeted anti-vascular therapies for ovarian cancer: current evidence

J Ledermann, M. Gore, J. Ledermann, 2013, British Journal of Cancer.

New paradigms in the treatment of breast and colorectal cancer--an introduction.

S Kaye, 2002, European journal of cancer.

Coping with toxicities of docetaxel (Taxotere).

J. Wanders, L. Dirix, A. V. van Oosterom, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.